AR 25Alternative Names: AR25
Latest Information Update: 27 Jul 2016
At a glance
- Originator Arbor Pharmaceuticals
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Registered Unspecified
Most Recent Events
- 25 Jul 2016 Registered for Undefined indication (unspecified route) before July 2016